Activaero GmbH, Germany
Leading aerosol inhalation technology
Leading aerosol inhalation technology
Webpage: www.vectura.com
BMI responsible: K. Fischer
Company status: Trade sale
BMI responsible: K. Fischer
Company status: Trade sale
Activaero GmbH, a spin-off from the German National Research Center GSF is the worldwide technology leader for controlled inhalation of aerosols. In March 2014, Activaero was acquired by the British Vectura Group plc.
Aleva Neurotherapeutics SA, Switzerland
Next-generation deep brain stimulation
Next-generation deep brain stimulation
Webpage: www.aleva-neuro.com
BMI responsible: M. Hosang
Company status: Private
BMI responsible: M. Hosang
Company status: Private
Aleva Neurotherapeutics SA with its headquarter at the EPFL Campus in Lausanne develops next-generation implants for Deep Brain Stimulation (DBS) in major neurological indications such as Parkinson's disease or depression.
Anergis SA, Switzerland
Peptide-based immunotherapies for allergies
Peptide-based immunotherapies for allergies
Webpage: www.anergis.ch
BMI responsible: M. Hosang
Company status: Private
BMI responsible: M. Hosang
Company status: Private
Anergis SA, based in Epalinges (CH), develops and markets peptide-based immunotherapies for the treatment of common allergies.
Ayoxxa Biosystems GmbH, Germany
Multiplexed protein analysis
Multiplexed protein analysis
Webpage: www.ayoxxa.com
BMI responsible: K. Fischer
Company status: Private
BMI responsible: K. Fischer
Company status: Private
Ayoxxa Biosystems GmbH, based in Köln (D), is a spin-off from the National University of Singapore which develops a proprietary technology platform for multiplexed protein analysis. This technology enables multiplex analysis in very small volumes with a very high robustness.
Curetis AG, Germany
Rapid solutions for the diagnosis of severe infectious diseases
Rapid solutions for the diagnosis of severe infectious diseases
Webpage: www.curetis.com
BMI responsible: K. Fischer
Company status: Public
BMI responsible: K. Fischer
Company status: Public
Curetis AG, located in Holzgerlingen (D), is a molecular diagnostic company focusing on the development and commercialization of reliable, fast and cost-effective tools for diagnosing severe infectious diseases.
Evolva Holding SA, Switzerland
Innovative sustainable ingredients for health, wellness and nutrition
Innovative sustainable ingredients for health, wellness and nutrition
Webpage: www.evolva.com
BMI responsible: M. Hosang
Company status: Public
BMI responsible: M. Hosang
Company status: Public
Evolva Holding SA is a Swiss-listed (SIX: EVE), international biotech company with its headquarters in Reinach, near Basel. Its mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create and optimise small molecule compounds and their production routes.
Genkyotex S.A., France & Switzerland
Selective NOX inhibitors for hard-to-treat chronic diseases
Selective NOX inhibitors for hard-to-treat chronic diseases
Webpage: www.genkyotex.com
BMI responsible: M. Hosang
Company status: Private
BMI responsible: M. Hosang
Company status: Private
Genkyotex S.A., based in St. Julien-en-Genevois (F) and Geneva (CH), is the leading developer of targeted NADPH Oxidase (NOX) inhibitors, with its lead compound in Ph II diabetic nephropathy.
Webpage: www.hookipa-biotech.com
BMI responsible: M. Hosang
Company status: Private
BMI responsible: M. Hosang
Company status: Private
Hookipa Biotech AG, based in Vienna (A), is developing a new class of innovative prophylactic and therapeutic vaccines based on its proprietary Vaxwave® technology. The Vaxwave® technology is a novel vaccine platform using a replication-defective viral vector for the prevention and treatment of multiple infectious diseases and cancer.
Humedics GmbH, Germany
Innovative non-invasive liver function analysis
Innovative non-invasive liver function analysis
Webpage: www.humedics.de
BMI responsible: K. Fischer
Company status: Private
BMI responsible: K. Fischer
Company status: Private
Humedics GmbH, headquartered in Berlin (D) and founded in 2010, has an innovative breath analysis device that makes instant bedside measurement of liver functions of patients with critical liver failure.
ImevaX GmbH, Germany
Immune evasion vaccines for chronic and nosocomial infections
Immune evasion vaccines for chronic and nosocomial infections
Webpage: www.imevax.com
BMI responsible: M. Hosang
Company status: Private
BMI responsible: M. Hosang
Company status: Private
ImevaX GmbH is a spin-off from Technische Universität München which develops highly specific vaccines against pathogens which cause chronic infectious diseases.
Inotrem S.A., France
Critical care treatments
Critical care treatments
Webpage: www.inotrem.com
BMI responsible: T. Möller
Company status: Private
BMI responsible: T. Möller
Company status: Private
Inotrem S.A. is a French biotech company specializing in the discovery and development of novel treatments in the field of inflammatory pathologies with a special focus on critical care.
Middle Peak Medical, Germany
Novel solutions for the treatment of mitral valve disease
Novel solutions for the treatment of mitral valve disease
Webpage: www.middlepeak-medical.com
BMI responsible: T. Möller
Company status: Private
BMI responsible: T. Möller
Company status: Private
Middle Peak Medical, based in Munich (D), is a medical device company, focusing on the development of a break-through device to meet unmet needs in the treatment of mitral valve disease. In February 2017, Middle Peak Medical was acquired by Symetis SA, a BioMedInvest AG I Portfolio company.
Miracor Medical Systems GmbH, Austria
Cutting-edge novel technology for cardiac care
Cutting-edge novel technology for cardiac care
Webpage: www.miracor-medical.com
BMI responsible: P. Burgermeister
Company status: Private
BMI responsible: P. Burgermeister
Company status: Private
Miracor Medical Systems GmbH is an Austrian medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Their PICSO Impulse System consists of a console and catheters and is CE marked. In clinical trials, PICSO has successfully demonstrated a reduction in infarct size in acute heart attack patients.
Sequana Medical AG, Switzerland
Implantable fluid management systems
Implantable fluid management systems
Webpage: www.sequana-medical.com
BMI responsible: T. Möller
Company status: Private
BMI responsible: T. Möller
Company status: Private
Sequana Medical AG is a Swiss medical device company, headquartered in Zug, dedicated to improving patient lives through the development, manufacture and commercialization of innovative implantable pump systems to manage fluid balance within the body.
Vaximm AG, Germany
Novel therapies in immuno-oncology
Novel therapies in immuno-oncology
Webpage: www.vaximm.com
BMI responsible: P. Burgermeister
Company status: Private
BMI responsible: P. Burgermeister
Company status: Private
VAXIMM AG is a spin-out vaccine company from MerckSerono and primarily focuses on developing active immunotherapies (vaccines) for patients suffering from cancer. The initial product candidate VXM01 is targeting the tumour vasculature, which is essential for tumours to grow beyond microscopic size.
Ventaleon GmbH, Germany
Inhaled Lysine Acetylsalicylate Glycine programme
Inhaled Lysine Acetylsalicylate Glycine programme
Webpage: www.activaero.de
BMI responsible: K. Fischer
Company status: Private
BMI responsible: K. Fischer
Company status: Private
Ventaleon GmbH, based in Gauting (D), is a spin-off of Activaero GmbH which develops inhaled Lysine Acetylsalicylate Glycine programme for the treatment of severe hospitalized influenza.